<qa>  What is the last line of therapy for MM?Part B: Diagnosis of MM with relapsed or refractory disease with previous exposure to PI e.g., bortezomib or carfilzomib, IMiDs e.g., lenalidomide or pomalidomide, and daratumumab, and refractory based on IMWG criteria to their last line of therapy 